<DOC>
	<DOCNO>NCT00033033</DOCNO>
	<brief_summary>The purpose study assess efficacy safety reserpine treatment cocaine dependence .</brief_summary>
	<brief_title>Reserpine Treatment Cocaine Dependence - 1</brief_title>
	<detailed_description>To assess efficacy safety reserpine reduce cocaine use subject cocaine dependence . This double-blind , placebo-controlled , parallel-group design 2 week baseline period .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Reserpine</mesh_term>
	<criteria>Be least 18 yrs age ; DSM4 diagnosis cocaine dependence ; treatment seek individual ; ability understand provide write informed consent ; female child bear potential use appropriate birth control method Additional criterion available screen site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>